Blockade of diabetic vascular injury by controlling of AGE-RAGE system

Khin Mar Myint1, Yasuhiko Yamamoto, Shigeru Sakurai

  • 1Department of Biochemistry & Molecular Vascular Biology, Kanazawa University Graduate School of Medical Science, Japan.

Current Drug Targets
|July 20, 2005
PubMed

Insights

Diabetic vascular complications stem from advanced glycation endproducts (AGEs) and their receptor RAGE. Targeting the AGE-RAGE system offers a promising strategy for preventing and treating these debilitating conditions.

Area of Science:

  • Endocrinology and Metabolism
  • Cardiovascular Research
  • Molecular Biology

Background:

  • Diabetic patients face significant disability and mortality due to vascular complications.
  • Prolonged hyperglycemia accelerates the formation and accumulation of advanced glycation endproducts (AGEs).
  • AGEs and their receptor RAGE are implicated in the vascular cell dysfunction observed in diabetes.

Purpose of the Study:

  • To investigate the role of the AGE-RAGE system in diabetic vascular complications.
  • To identify the AGE-RAGE axis as a potential molecular target for therapeutic intervention.

Main Methods:

  • In vitro and in vivo studies were conducted to examine AGE and RAGE interactions.
  • Analysis of AGE formation, accumulation, and crosslinking of proteins.
  • Evaluation of RAGE signaling pathways in vascular cells.

Main Results:

  • The AGE-RAGE system was identified as a key mediator of vascular cell derangement in diabetes.
  • Evidence supports the direct contribution of AGEs and RAGE to diabetic vascular pathology.

Conclusions:

  • The AGE-RAGE system represents a critical molecular target for managing diabetic vascular complications.
  • Therapeutic strategies could involve inhibiting AGE formation, breaking AGE crosslinks, blocking AGE-RAGE interaction, or inhibiting RAGE signaling.

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Insipidus II: Pathophysiology01:22

Diabetes Insipidus II: Pathophysiology

Normally, water balance is maintained through three interconnected mechanisms: the hypothalamic thirst center, the synthesis and release of antidiuretic hormone (ADH, or vasopressin), and the kidneys' responsiveness to this hormone. ADH is synthesized in the hypothalamus, released from the posterior pituitary, and acts on the distal nephron, allowing water reabsorption and concentrated urine production.Diabetes Insipidus and Its TypesIn diabetes insipidus (DI), this regulatory system is...